Targeting LAT1-mediated amino acid transport in innate and adaptive T cells efficiently controls skin inflammation.

[1]  S. Auriola,et al.  L-Type amino acid transporter 1 as a target for drug delivery , 2020, Pharmaceutical Research.

[2]  Xin Zhao,et al.  Structure of the human LAT1–4F2hc heteromeric amino acid transporter complex , 2019, Nature.

[3]  C. Buerger.  Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target , 2018, Front. Immunol..

[4]  M. Lindberg,et al.  Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma† , 2018, The British journal of dermatology.

[5]  E. Ward,et al.  BCAP links IL-1R to the PI3K–mTOR pathway and regulates pathogenic Th17 cell differentiation , 2018, The Journal of experimental medicine.

[6]  David K. Finlay,et al.  Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice , 2018, Nature Communications.

[7]  J. Furuse,et al.  First-in-human phaseIstudy of JPH203 in patients with advanced solid tumors. , 2018 .

[8]  E. Lee,et al.  Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses , 2018, Front. Immunol..

[9]  K. Kumamoto,et al.  L-type amino acid transporter 1 expression is upregulated and associated with cellular proliferation in colorectal cancer. , 2017, Oncology letters.

[10]  T. Korn,et al.  IL-1β and IL-23 Promote Extrathymic Commitment of CD27+CD122− γδ T Cells to γδT17 Cells , 2017, The Journal of Immunology.

[11]  R. Clark,et al.  Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing &agr;&bgr; T cell clones , 2017, The Journal of clinical investigation.

[12]  J. Krueger,et al.  Psoriasis pathogenesis and the development of novel targeted immune therapies , 2017, The Journal of allergy and clinical immunology.

[13]  B. Stockinger,et al.  IL‐23 drives differentiation of peripheral γδ17 T cells from adult bone marrow‐derived precursors , 2017, EMBO reports.

[14]  P. Wolf,et al.  Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation , 2017, PloS one.

[15]  Russell G. Jones,et al.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells. , 2017, Immunity.

[16]  J. Krueger,et al.  Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis. , 2017, Annual review of medicine.

[17]  N. Anzai,et al.  Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment , 2017, World journal of gastrointestinal oncology.

[18]  D. Zaller,et al.  Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity. , 2016, Cell reports.

[19]  F. Sánchez‐Madrid,et al.  CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis , 2016, Nature Immunology.

[20]  F. Villanova,et al.  Targeting CD8(+) T cells prevents psoriasis development. , 2016, The Journal of allergy and clinical immunology.

[21]  J. Renauld,et al.  AhR modulates the IL‐22‐producing cell proliferation/recruitment in imiquimod‐induced psoriasis mouse model , 2016, European journal of immunology.

[22]  D. Absher,et al.  Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis. , 2016, The Journal of investigative dermatology.

[23]  P. Miossec,et al.  IL-17 in Chronic Inflammation: From Discovery to Targeting. , 2016, Trends in molecular medicine.

[24]  B. Becher,et al.  Dermal IL‐17‐producing γδ T cells establish long‐lived memory in the skin , 2015, European journal of immunology.

[25]  T. Oyama,et al.  Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma , 2015, Melanoma research.

[26]  H. Mizutani,et al.  "Inflammatory skin march": IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events. , 2015, The Journal of allergy and clinical immunology.

[27]  Elizabeth E Gray,et al.  Inflammation induces dermal Vγ4+ γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17–driven responses , 2015, Proceedings of the National Academy of Sciences.

[28]  H. Koenen,et al.  Cellular sources of IL‐17 in psoriasis: a paradigm shift? , 2014, Experimental dermatology.

[29]  A. Kurata,et al.  Expression of L-type amino acid transporter 1 in various skin lesions. , 2014, Pathology, research and practice.

[30]  B. Silva-Santos,et al.  Molecular Mechanisms of Differentiation of Murine Pro-Inflammatory γδ T Cell Subsets , 2013, Front. Immunol..

[31]  F. Villanova,et al.  Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis , 2013, The Journal of investigative dermatology.

[32]  H. Endou,et al.  LAT1 Is a Critical Transporter of Essential Amino Acids for Immune Reactions in Activated Human T Cells , 2013, The Journal of Immunology.

[33]  R. Morita,et al.  Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation , 2013, The Journal of Immunology.

[34]  Linda V. Sinclair,et al.  Antigen receptor control of amino acid transport coordinates the metabolic re-programming that is essential for T cell differentiation , 2013, Nature immunology.

[35]  V. Kuchroo,et al.  MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling , 2013, Proceedings of the National Academy of Sciences.

[36]  K. Okkenhaug,et al.  Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis , 2012, The Journal of Immunology.

[37]  F. Sallusto,et al.  Human Th17 subsets , 2012, European journal of immunology.

[38]  B. Becher,et al.  Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. , 2012, The Journal of clinical investigation.

[39]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[40]  A. Hayday,et al.  Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis , 2011, The Journal of Immunology.

[41]  A. Blauvelt,et al.  IL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A , 2011, The Journal of Immunology.

[42]  D. Kasper,et al.  Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. , 2010, Cell host & microbe.

[43]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[44]  Eva Tolosa,et al.  Phenotypical Characterization of Human Th17 Cells Unambiguously Identified by Surface IL-17A Expression1 , 2009, The Journal of Immunology.

[45]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[46]  R. Nurieva,et al.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.

[47]  Y. Sung,et al.  STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice1 , 2006, The Journal of Immunology.

[48]  J. Fort,et al.  The genetics of heteromeric amino acid transporters. , 2005, Physiology.

[49]  D. Littman,et al.  Thymic Origin of Intestinal αß T Cells Revealed by Fate Mapping of RORγt+ Cells , 2004, Science.

[50]  M. Feldmann,et al.  Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. , 2004, Blood.

[51]  S. Bröer,et al.  Function and structure of heterodimeric amino acid transporters. , 2001, American journal of physiology. Cell physiology.

[52]  K. Yoshikawa,et al.  Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Littman,et al.  A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development , 1994, Cell.

[54]  P. Taylor.  Role of amino acid transporters in amino acid sensing. , 2014, The American journal of clinical nutrition.

[55]  K. Nakagawa,et al.  Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy. , 2008, Cytotherapy.